The Beck Anxiety Inventory (BAI) is a brief self-report measure of the severity of anxiety symptoms in adults and adolescents, built by Aaron Beck's group to capture the somatic and physiological signs of anxiety that are least shared with depression.
Because most of its items describe physical arousal, the BAI overlaps heavily with panic symptomatology; it detects panic disorder more accurately than any other anxiety disorder and is weaker for worry-dominated presentations such as generalized anxiety.
Reliability is consistently high across psychiatric, undergraduate, and older medical samples, and the total score correlates with clinician-rated anxiety (HARS r = 0.51) more strongly than with clinician-rated depression (HDRS r = 0.25), supporting the discriminant purpose it was designed for.
Its severity bands were set from clinical experience and have never been validated against a diagnostic gold standard, and the instrument is commercially licensed through Pearson Assessments rather than free to reproduce.
At a Glance
Items
21 symptom items
Administration time
5-10 minutes self-administered; about 10 minutes when read aloud (Beck & Steer, 1993)
Response format
4-point severity scale (0 = not at all to 3 = severely), each symptom rated for the past week, including today
Subscales or Scores
Single total score (0-63) with four descriptive severity bands (minimal, mild, moderate, severe)
Validated populations or ages
Ages 17-80 (publisher); adolescent psychiatric samples aged 12-17 have also been studied
License
Commercial. Copyright Aaron T. Beck; a registered trademark of The Psychological Corporation; published and licensed by Pearson Assessments
Original citation
Beck, Epstein, Brown, & Steer (1988), Journal of Consulting and Clinical Psychology
Introduction
The Beck Anxiety Inventory (BAI) is a 21-item self-report measure of the severity of anxiety symptoms in adults and adolescents. Developed by Aaron T. Beck and colleagues (Beck, Epstein, Brown, & Steer, 1988), it was constructed to address a persistent problem in anxiety assessment: many existing anxiety scales overlapped substantially with depression, making it difficult to measure anxiety as a distinct construct. The BAI approaches the problem by concentrating on the somatic and physiological manifestations of anxiety, the symptom domain least shared with depression.
Understanding Anxiety’s Somatic Signature
Although anxiety and depression both involve negative mood, anxiety is distinctively associated with signs of autonomic arousal: cardiovascular symptoms (heart pounding or racing), respiratory symptoms (shortness of breath, sensations of choking or smothering), neurological symptoms (trembling, dizziness, numbness or tingling), gastrointestinal distress (nausea), and thermoregulatory changes (hot or cold flashes, sweating not due to heat). These somatic symptoms reflect activation of the sympathetic nervous system, the “fight or flight” response, and they anchor the BAI’s item content.
The instrument is deliberately weighted toward this physical side of anxiety: 15 of the 21 items relate to physical symptoms (Creamer et al., 1995), and a finer breakdown places 13 items as clearly physical or physiological, 5 as clearly cognitive, and 3 with both a physical and a cognitive connotation (Fydrich et al., 1992).
Theoretical Foundation
While Beck is best known for his cognitive model of depression, his work on anxiety emphasized threat perception and danger-related cognitions. The BAI reflects this perspective by combining physical symptoms of autonomic arousal, the body’s preparation for danger (heart racing, sweating, trembling), with cognitive-perceptual symptoms of fear and threat appraisal (fear of dying, fear of losing control, feeling terrified).
The physiological emphasis has a measurable consequence: BAI item content overlaps heavily with panic symptomatology, and the inventory detects panic disorder more accurately than any other anxiety disorder (Leyfer et al., 2006).
⚡ Panic disorder specialty: Because most BAI items tap physiological arousal, the scale discriminates panic disorder from other anxiety disorders better than any other diagnostic group, making it well suited to panic-focused assessment and research (Leyfer et al., 2006).
Key Features
Assessment Characteristics
21 items describing physical and cognitive symptoms of anxiety
5-10 minutes to complete when self-administered (Beck & Steer, 1993)
4-point severity scale (0-3) for each item
Past-week timeframe (“during the past week, including today”) for symptom ratings
Ages 17 and older, with adolescent psychiatric data for ages 12-17 (Kumar, Steer, & Beck, 1993; Steer et al., 1995)
Commercially licensed measure requiring purchase from Pearson Assessments
Dimensions Assessed
Somatic anxiety – 15 of the 21 items relate to physical symptoms across cardiovascular, respiratory, neurological, and gastrointestinal domains (Creamer et al., 1995)
Cognitive-perceptual anxiety – fear of the worst happening, fear of losing control, fear of dying (items 5, 14, and 16)
Four descriptive symptom clusters – neurophysiological, subjective, autonomic, and panic, from the manual’s cluster analysis (Beck & Steer, 1993, pp. 16-17)
Versions & Adaptations
Original 21-item BAI (Beck et al., 1988)
BAI for Primary Care (BAI-PC), a brief adaptation developed for medical outpatients in primary-care settings (Beck, Steer, Ball, Ciervo, & Kabat, 1997)
Translations with published psychometric evaluations include Spanish (Sanz, García-Vera, & Fortún, 2012), German (Margraf & Ehlers, 2007), and Chinese (Che et al., 2006); validated translations exist in several other languages
No other published short forms were identified during verification
Research Applications
Panic disorder assessment – particularly sensitive to panic symptomatology (Leyfer et al., 2006)
Anxiety severity measurement – tracking symptom intensity over time
Anxiety-depression differentiation – item content minimally shared with depressive symptoms
Treatment outcome research – a standard severity measure in anxiety treatment studies
Psychotherapy and pharmacotherapy monitoring – tracking reductions in somatic anxiety across treatment
Assess anxiety severity with focus on somatic and physical symptom manifestations.
Scoring and Interpretation
Response Format
Respondents rate how much they have been bothered by each symptom during the past week, including today, on a 4-point severity scale:
0 = Not at all
1 = Mildly; it did not bother me much
2 = Moderately; it was very unpleasant, but I could stand it
3 = Severely; I could barely stand it
Response anchors as given in the BAI manual (Beck & Steer, 1993, p. 2).
Illustrative Items
The BAI is a commercially licensed instrument, so the full item set is not reproduced here. Four genuine items illustrate the content:
Numbness or tingling
Unable to relax
Heart pounding or racing
Fear of losing control
Scoring Procedure
Sum all 21 item responses (total range 0-63).
Higher scores indicate greater anxiety severity.
Individual items and symptom clusters can be examined descriptively, but the total score remains the standard metric.
BAI Severity Classification
Total Score
Severity Level
0-7
Minimal anxiety
8-15
Mild anxiety
16-25
Moderate anxiety
26-63
Severe anxiety
These ranges were set by the test’s authors from clinical experience (Beck & Steer, 1993). As Wetherell and Areán (1997, p. 143) note, the “suggested cut points have been proposed by the authors of the measure but have not been tested against an agreed-on gold standard,” so the bands describe severity rather than establishing validated diagnostic thresholds.
Interpretation Points
Score ≥16: falls in the moderate range or higher; Beck and Steer (1993) describe scores of 16 or above as suggesting moderate to severe levels of anxiety (as applied in Wetherell & Areán, 1997, p. 138)
Score ≥26: falls in the severe range
Items 5, 14, 16: the BAI’s cognitive fear items (fear of the worst happening, fear of losing control, fear of dying)
Items 7, 11, 15 (with 16): form the empirically derived panic cluster (Beck & Steer, 1991; Leyfer et al., 2006)
Descriptive Group Means
The values below are descriptive sample means, not diagnostic norms or cutoffs. Leyfer et al. (2006, Table 1) assessed 193 adults recruited to an anxiety research and treatment center; the manual’s outpatient sample (N = 393) provides comparable diagnostic-group means (Beck & Steer, 1993, Table 4; corroborated in Creamer et al., 1995, p. 484).
Sample
N
M
SD
Source
Anxiety-clinic sample, all participants
193
12.3
13.9
Leyfer et al. (2006)
Panic disorder
—
26.6
14.4
Leyfer et al. (2006)
Obsessive-compulsive disorder
—
18.7
13.1
Leyfer et al. (2006)
Social or specific phobia
—
15.8
16.9
Leyfer et al. (2006)
Generalized anxiety disorder
—
10.3
7.5
Leyfer et al. (2006)
No psychiatric diagnosis
—
2.5
2.8
Leyfer et al. (2006)
Panic disorder with agoraphobia (outpatients)
—
27.27
13.11
Beck & Steer (1993, Table 4)
Panic disorder without agoraphobia (outpatients)
—
28.81
13.46
Beck & Steer (1993, Table 4)
Generalized anxiety disorder (outpatients)
—
18.83
9.08
Beck & Steer (1993, Table 4)
Social phobia (outpatients)
44
17.77
11.64
Beck & Steer (1993, Table 4)
Meaningful Change
Score below 8: falls in the minimal range
50% reduction: a generic responder convention used across anxiety trials, not a BAI-specific criterion; no published BAI reliable-change index was identified during verification
Research Evidence and Psychometric Properties
Reliability Evidence
Internal consistency:
Clinical (psychiatric) samples: α = 0.92 (Beck et al., 1988; cited in Fydrich et al., 1992, Creamer et al., 1995, and Leyfer et al., 2006)
Anxiety-disorder outpatients: α = 0.94 (Fydrich et al., 1992, N = 40, p. 59)
Non-clinical (undergraduate) sample: α = 0.90-0.91 (Creamer et al., 1995, N = 326, Table 1)
Older medical patients: α = 0.92 (Wetherell & Areán, 1997, N = 197, ages 55-92, p. 138)
Test-retest reliability:
1-week interval: r = 0.75 (Beck et al., 1988); Fydrich’s 7-day subsample gave r = 0.73 (n = 26)
~11-day interval: r = 0.67 in anxiety-disorder outpatients (Fydrich et al., 1992, N = 40, p. 58)
7-week interval: r = 0.62 in a non-clinical sample (Creamer et al., 1995, N = 326, Table 1)
Validity Evidence
Convergent validity with anxiety measures:
State-Trait Anxiety Inventory: r = 0.58 (Trait) and r = 0.47 (State) in anxiety-disorder outpatients (Fydrich et al., 1992, Table 1)
Hamilton Anxiety Rating Scale: r = 0.51 with the clinician-rated scale (Beck et al., 1988; corroborated by Fydrich et al., 1992, p. 56 and Creamer et al., 1995, p. 479)
Discriminant validity from depression:
Beck Depression Inventory: r = 0.48 (Beck et al., 1988; Creamer et al., 1995, p. 479)
Hamilton Depression Rating Scale: r = 0.25, a low correlation demonstrating successful differentiation from depression (Beck et al., 1988)
Factor Structure
Two-factor model: somatic symptoms and subjective anxiety/panic (Beck et al., 1988; described in Creamer et al., 1995 and Leyfer et al., 2006)
Four-factor model: neurophysiological, subjective, autonomic, and panic factors (Beck & Steer, 1991; confirmed by Osman et al., 1997). Hewitt and Norton (1993) instead reported a two-factor (cognitive, somatic) solution
Hierarchical model: a general anxiety factor with specific symptom clusters (Osman et al., 1997)
Clinical utility: the total score remains the standard, most reliable metric despite varying factor structures across studies
Clinical Group Differentiation and Screening
Panic disorder scored highest of all diagnostic groups in an anxiety-clinic sample (Leyfer et al., 2006, Table 1; see the group-means table in Scoring and Interpretation)
In this sample the BAI separated panic disorder from other anxiety groups and from non-anxious individuals (Leyfer et al., 2006)
Screening for panic disorder: in ROC analyses, an optimal BAI cutoff of 8.5 identified panic disorder with sensitivity 0.89 and specificity 0.97, whereas the total score could not adequately detect the other anxiety disorders (Leyfer et al., 2006)
Treatment Sensitivity
Cognitive-behavioral therapy: CBT produces medium-to-large reductions on continuous anxiety-severity measures (pooled Hedges g = 0.73; Hofmann & Smits, 2008)
Treatment monitoring: tracks symptom reduction across various anxiety treatments
Cross-Cultural Validation
Spanish version: good psychometric properties reported for the Spanish adaptation (Sanz, García-Vera, & Fortún, 2012)
German adaptation: available with manual-reported psychometrics (Margraf & Ehlers, 2007)
Chinese validation: good psychometric properties in Chinese populations (Che et al., 2006)
Multiple languages: validated translations available in several languages
Demographic Effects
Gender differences:
Women score up to about 4 points higher than men on average (Beck & Steer, 1993; corroborated in Creamer et al., 1995, p. 478)
Consider gender norms when interpreting individual scores
Whether this reflects genuine prevalence differences or measurement factors remains an open question
Age effects:
Age effects are small and inconsistent across samples: no age effect in a non-clinical undergraduate sample (Creamer et al., 1995), but a significant negative correlation, with older patients scoring lower, among older medical patients (Wetherell & Areán, 1997, r = −.20)
Adolescent data exist for ages 12-17 (Kumar, Steer, & Beck, 1993; Steer et al., 1995)
Most appropriate for respondents aged 17 and older; validation below 17 is more limited
Usage Guidelines and Applications
Primary Clinical Applications
Anxiety disorder severity assessment in mental health and medical settings
Panic disorder evaluation given strong correspondence with panic symptoms
Treatment outcome monitoring for both psychotherapy and pharmacotherapy
Anxiety-depression differentiation in comorbid presentations
Clinical research as a standard outcome measure in anxiety treatment studies
Administration Requirements
Qualified use only: requires appropriate training in psychological assessment
Professional supervision required for graduate students
Clinical interpretation should be performed by licensed mental health professionals
Diagnostic Considerations
High somatic symptom scores:
Are consistent with panic-spectrum presentations given the BAI’s physiological weighting
Can be examined alongside cardiovascular and respiratory item clusters
Cognitive fear items (14, 16):
Items 14 (fear of losing control) and 16 (fear of dying) capture catastrophic fear content
Can inform assessment of catastrophic misinterpretation of body sensations
Medical symptom overlap:
Rule out medical conditions causing anxiety-like physical symptoms
Interpret somatic items cautiously in cardiac, respiratory, or chronic pain conditions
Treatment Monitoring Applications
Baseline assessment:
Establish pre-treatment severity and symptom profile
Identify specific symptom targets (e.g., cardiovascular, respiratory)
Set treatment goals based on presenting symptoms
During treatment: (general practice suggestions, not BAI-specific guidance)
Re-administer periodically during the active treatment phase
Track the total score and individual symptom clusters
Review the treatment plan if there is insufficient improvement
Outcome evaluation:
Post-treatment assessment at therapy conclusion
Follow-up assessments to monitor relapse prevention
Scores below 8 fall in the minimal range
Special Populations Considerations
Medical patients:
Rule out physical conditions that produce anxiety-like symptoms
Older adults:
Valid and reliable in older adults: internal consistency α = 0.92 and adequate discriminant validity in older medical outpatients (Wetherell & Areán, 1997)
Medical symptoms can be confused with anxiety symptoms; consider medical evaluation to rule out physical causes
Panic disorder patients:
Most items tap physiological arousal, and the BAI detects panic disorder more accurately than other anxiety disorders (Leyfer et al., 2006)
Well suited to tracking panic symptom reduction
GAD patients:
May underestimate worry-based anxiety symptoms
Less sensitive to the cognitive aspects of GAD than worry-focused measures like the GAD-7 (Leyfer et al., 2006; Creamer et al., 1995)
Consider supplementing with a worry-focused assessment
Cultural Considerations
Use a published, validated translation where one exists (Sanz et al., 2012; Margraf & Ehlers, 2007; Che et al., 2006)
Consider cultural adaptations for diverse populations
Limitations and Cautions
Somatic symptom bias: may overestimate anxiety in medical populations with physical symptoms
Limited cognitive assessment: less comprehensive coverage of worry and rumination than some measures
Age restrictions: most appropriate for ages 17 and older; more limited validation below 17
Copyright requirements: must be purchased from Pearson Assessments for legal use
Measures one aspect of anxiety: weighted toward physiological/panic symptoms, so it may not capture anxiety that is primarily cognitive or behavioural (Leyfer et al., 2006; Creamer et al., 1995)
Not diagnostic alone: a clinical interview is required for a definitive anxiety disorder diagnosis
Copyright and Usage Responsibility: Check that you have the proper rights and permissions to use this assessment tool in your research. This may include purchasing appropriate licenses, obtaining permissions from authors/copyright holders, or ensuring your usage falls within fair use guidelines.
The Beck Anxiety Inventory (BAI) is copyrighted material. Copyright is held by Aaron T. Beck; the BAI is a registered trademark of The Psychological Corporation and is published and licensed by Pearson Assessments. The BAI requires proper licensing for administration in clinical practice and research settings. Item content is reproduced on this page only in brief illustrative form.
Usage Requirements:
Clinical use: requires purchase of test materials and scoring rights from Pearson Assessments
Research use: requires permission and proper licensing agreements
Educational use: contact Pearson for academic licensing options
Commercial use: requires a comprehensive licensing agreement
Proper Attribution: When using or referencing this scale, cite the original development:
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893-897. https://doi.org/10.1037/0022-006X.56.6.893
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893-897. https://doi.org/10.1037/0022-006X.56.6.893
Manual and Short Form:
Beck, A. T., & Steer, R. A. (1993). Beck Anxiety Inventory manual. San Antonio, TX: The Psychological Corporation. (no DOI)
Beck, A. T., Steer, R. A., Ball, R., Ciervo, C. A., & Kabat, M. (1997). Use of the Beck Anxiety and Depression Inventories for primary care with medical outpatients. Assessment, 4, 211-219. (no DOI verified)
Psychometric Studies:
Beck, A. T., & Steer, R. A. (1991). Relationship between the Beck Anxiety Inventory and the Hamilton Anxiety Rating Scale with anxious outpatients. Journal of Anxiety Disorders, 5(3), 213-223. https://doi.org/10.1016/0887-6185(91)90002-B
Creamer, M., Foran, J., & Bell, R. (1995). The Beck Anxiety Inventory in a non-clinical sample. Behaviour Research and Therapy, 33(4), 477-485. https://doi.org/10.1016/0005-7967(94)00082-U
Fydrich, T., Dowdall, D., & Chambless, D. L. (1992). Reliability and validity of the Beck Anxiety Inventory. Journal of Anxiety Disorders, 6(1), 55-61. https://doi.org/10.1016/0887-6185(92)90026-4
Wetherell, J. L., & Areán, P. A. (1997). Psychometric evaluation of the Beck Anxiety Inventory with older medical patients. Psychological Assessment, 9(2), 136-144. https://doi.org/10.1037/1040-3590.9.2.136
Leyfer, O. T., Ruberg, J. L., & Woodruff-Borden, J. (2006). Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. Journal of Anxiety Disorders, 20(4), 444-458. PMID 16005177
Factor Structure Research:
Hewitt, P. L., & Norton, G. R. (1993). The Beck Anxiety Inventory: A psychometric analysis. Psychological Assessment, 5(4), 408-412. https://doi.org/10.1037/1040-3590.5.4.408
Kumar, G., Steer, R. A., & Beck, A. T. (1993). The utility of the Beck Anxiety Inventory with inpatient adolescents. Journal of Anxiety Disorders, 7, 125-131. (no DOI)
Steer, R. A., Kumar, G., Ranieri, W. F., & Beck, A. T. (1995). Use of the Beck Anxiety Inventory with adolescent psychiatric outpatients. Psychological Reports, 76(2), 459-465. https://doi.org/10.2466/pr0.1995.76.2.459
Treatment Sensitivity:
Hofmann, S. G., & Smits, J. A. (2008). Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials. Journal of Clinical Psychiatry, 69(4), 621-632. https://doi.org/10.4088/JCP.v69n0415
Cross-Cultural Studies:
Sanz, J., García-Vera, M. P., & Fortún, M. (2012). El “Inventario de Ansiedad de Beck” (BAI): propiedades psicométricas de la versión española en pacientes con trastornos psicológicos. Behavioral Psychology/Psicología Conductual, 20(3), 563-583. (no DOI)
Margraf, J., & Ehlers, A. (2007). Beck Angst-Inventar (BAI). Manual. Deutsche Bearbeitung. Frankfurt am Main: Harcourt Test Services. (no DOI)
Che, H.-H., Lu, M.-L., Chen, H.-C., Chang, S.-W., & Lee, Y.-J. (2006). Validation of the Chinese version of the Beck Anxiety Inventory. Formosan Journal of Medicine, 10(4), 447-454. (no DOI)
A hummingbird hovering in constant motion — embodying the rapid heartbeat, restlessness, and physical tension measured by the BAI (Beck Anxiety Inventory)
Frequently Asked Questions
What does the BAI measure?
The Beck Anxiety Inventory (BAI) measures the severity of anxiety symptoms in adults and adolescents, with particular emphasis on somatic and physiological manifestations: 15 of its 21 items relate to physical symptoms such as cardiovascular, respiratory, and neurological sensations (Creamer et al., 1995). It was constructed to measure anxiety with minimal overlap with depression.
How long does the BAI take to complete?
About 5 to 10 minutes when self-administered, and roughly 10 minutes when read aloud (Beck & Steer, 1993). Respondents rate 21 symptoms on a 4-point scale (0 to 3) according to how much each has bothered them during the past week, including today.
Is the BAI free to use?
No. Copyright is held by Aaron T. Beck, the BAI is a registered trademark of The Psychological Corporation, and the instrument is published and licensed by Pearson Assessments. Clinical, research, educational, and commercial uses all require the appropriate license from Pearson.
How is the BAI scored?
All 21 item responses are summed to a total between 0 and 63. The manual's descriptive severity bands are 0-7 (minimal), 8-15 (mild), 16-25 (moderate), and 26-63 (severe), and Beck and Steer (1993) describe scores of 16 or higher as suggesting moderate to severe anxiety. These cut points were set from clinical experience and have not been tested against a diagnostic gold standard (Wetherell & Areán, 1997).
How reliable is the BAI?
Internal consistency is high across populations: α = 0.92 in psychiatric samples (Beck et al., 1988), 0.94 in anxiety-disorder outpatients (Fydrich et al., 1992), 0.90-0.91 in undergraduates (Creamer et al., 1995), and 0.92 in older medical patients (Wetherell & Areán, 1997). Test-retest correlations decline with the interval, from r = 0.75 at one week (Beck et al., 1988) to r = 0.62 at seven weeks (Creamer et al., 1995).
What's the difference between the BAI and the GAD-7?
The BAI emphasizes somatic and physical symptoms across 21 items and is particularly good at detecting panic disorder, whereas the GAD-7 is a short worry-focused screener for generalized anxiety. Because the BAI is weighted toward physiological symptoms, it may underestimate worry-based anxiety in GAD relative to worry-focused measures (Leyfer et al., 2006; Creamer et al., 1995).
Can the BAI diagnose an anxiety disorder?
No. The BAI is a severity measure, not a diagnostic instrument. Its severity bands are descriptive labels that have not been validated against a diagnostic gold standard, and a clinical interview is required for any definitive anxiety disorder diagnosis. Screening research supports its use mainly for detecting panic disorder (Leyfer et al., 2006).
